Investor profile
Braavos Capital has backed 8 European tech companies across 8 funding rounds between 2021 and 2025, joining rounds totalling €318M. Most active in Healthtech and AI. Data as of 6 Aug 2026.
Also recorded as: Braavos Investment Advisers
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Osler Diagnostics | UK | 1 | €85M |
| Charm Therapeutics | UK | 1 | €47M |
| First Light Fusion | UK | 1 | €40M |
| PQShield | UK | 1 | €35M |
| Oxford Ionics | UK |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Osler Diagnostics | Series C | €85M | 2022-11 |
| Charm Therapeutics | Series A | €47M | 2022-06 |
| First Light Fusion | Series C | €40M | 2022-02 |
| PQShield |
| 1 |
| €34M |
| Salience Labs | UK | 1 | €29M |
| SpyBiotech | UK | 1 | €27M |
| Oxccu | UK | 1 | €21M |
| Series B |
| €35M |
| 2024-06 |
| Oxford Ionics | Series A | €34M | 2023-01 |
| Salience Labs | Series A | €29M | 2025-02 |
| SpyBiotech | Series A | €27M | 2021-02 |
| Oxccu | Series A | €21M | 2023-06 |
